Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9


Physical activity and reduced breast cancer risk: a multinational study.

Ratnasinghe LD, Modali RV, Seddon MB, Lehman TA.

Nutr Cancer. 2010;62(4):425-35. doi: 10.1080/01635580903441295.


A prospective study of polymorphisms of DNA repair genes XRCC1, XPD23 and APE/ref-1 and risk of stroke in Linxian, China.

Mahabir S, Abnet CC, Qiao YL, Ratnasinghe LD, Dawsey SM, Dong ZW, Taylor PR, Mark SD.

J Epidemiol Community Health. 2007 Aug;61(8):737-41.


Associations between catalase phenotype and genotype: modification by epidemiologic factors.

Ahn J, Nowell S, McCann SE, Yu J, Carter L, Lang NP, Kadlubar FF, Ratnasinghe LD, Ambrosone CB.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1217-22.


Decision forest analysis of 61 single nucleotide polymorphisms in a case-control study of esophageal cancer; a novel method.

Xie Q, Ratnasinghe LD, Hong H, Perkins R, Tang ZZ, Hu N, Taylor PR, Tong W.

BMC Bioinformatics. 2005 Jul 15;6 Suppl 2:S4.


Methylation profiling of archived non-small cell lung cancer: a promising prognostic system.

Safar AM, Spencer H 3rd, Su X, Coffey M, Cooney CA, Ratnasinghe LD, Hutchins LF, Fan CY.

Clin Cancer Res. 2005 Jun 15;11(12):4400-5.


CYP3A43 Pro(340)Ala polymorphism and prostate cancer risk in African Americans and Caucasians.

Stone A, Ratnasinghe LD, Emerson GL, Modali R, Lehman T, Runnells G, Carroll A, Carter W, Barnhart S, Rasheed AA, Greene G, Johnson DE, Ambrosone CB, Kadlubar FF, Lang NP.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1257-61.


Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer.

Ratnasinghe LD, Abnet C, Qiao YL, Modali R, Stolzenberg-Solomon R, Dong ZW, Dawsey SM, Mark SD, Taylor PR.

Cancer Lett. 2004 Dec 28;216(2):157-64.


Aspirin use and mortality from cancer in a prospective cohort study.

Ratnasinghe LD, Graubard BI, Kahle L, Tangrea JA, Taylor PR, Hawk E.

Anticancer Res. 2004 Sep-Oct;24(5B):3177-84.


Serum carotenoids and alpha-tocopherol and risk of nonmelanoma skin cancer.

Dorgan JF, Boakye NA, Fears TR, Schleicher RL, Helsel W, Anderson C, Robinson J, Guin JD, Lessin S, Ratnasinghe LD, Tangrea JA.

Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1276-82.

Supplemental Content

Loading ...
Support Center